Top Clinical Trials companies in Brazil by Revenue

This ranking features the top 2 Clinical Trials companies in Brazil ranked by Revenue, totaling a Revenue of USD 3.17 B, for February 05, 2025.

Brazil

Clinical Trials
Revenue
#
Name
Revenue
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
DASA3.SA

Diagnósticos da América S.A.

1

DASA3.SA
USD 2.93 B
Dec. 31, 2023 USD 0.31 -1.64%

Brazil
2
AALR3.SA

Centro de Imagem Diagnósticos S.A.

2

AALR3.SA
USD 242.64 M
Dec. 31, 2023 USD 1.95 -3.23%

Brazil
Frequently Asked Questions
  • Which Clinical Trials company in Brazil has the highest Revenue ?

    The Clinical Trials company in Brazil with the highest Revenue is Diagnósticos da América S.A. (São Paulo Stock Exchange: DASA3.SA) at USD 2.93 B.

  • Which Clinical Trials company in Brazil has the lowest Revenue ?

    The Clinical Trials company in Brazil with the lowest Revenue is Centro de Imagem Diagnósticos S.A. (São Paulo Stock Exchange: AALR3.SA) at USD 242.64 M.

SV Wall Street